Doulas can’t deliver babies or provide medical care, but they can help reduce birth trauma. Learn more about how doulas are beneficial and whether insurance plans cover the cost of birth support.
Need further assistance? Please call Member Services at 1-800-333-0663
The Safest Way to Get Your Health Screenings During COVID-19
Expert advice on handling colonoscopies and 5 other important tests By Hallie Levine
iStock
Many older adults in the United States who take daily pills to promote cardiovascular health and prevent events like heart attacks and strokes may be taking the wrong medicine, according to a study published in February 2021 in the
For the study, researchers examined data collected between 2011 and 2018 from 11,392 adults age 50 and older about their history of cardiovascular events and any use of aspirin, a common over-the-counter nonsteroidal anti-inflammatory drug (NSAID), or statins, prescription drugs that lower cholesterol.
Low-dose aspirin use was more common with older age, with more than 45 percent of people 75 and older taking the drug daily to help prevent a first-time cardiovascular event like a heart attack or stroke, a strategy known as primary prevention. The trouble with this is that aspirin has been shown to help prevent heart attacks and strokes in middle-aged adults, but not in the elderly, says the lead study author, Greg Rhee, PhD, an assistant profe
SHARE
ASCO GU 2021: Association of Reductions in PSA Screening Across States with Increased Metastatic Prostate Cancer in the United States
Published 13 February 2021
(UroToday.com) Prostate cancer screening using prostate-specific antigen (PSA) testing has been controversial since shortly after its introduction in large part due to concerns of over-diagnosis and over-treatment, with the associated morbidity. Thus, despite improvements in prostate cancer-related metastasis and mortality demonstrated in the European Randomized Study of Screening for Prostate Cancer (ERSPC) randomized trial from Europe, PSA screening has remained contentious. In both 2008 and 2012, the US Preventive Services Task Force (USPSTF) did not recommend PSA screening. Some have attributed increased rates of metastatic prostate cancer in the US to reductions in PSA screening as a result of these recommendations from the USPSTF. To test this hypothesis, in the Poster Highlights: Prostate Cancer - Localized
Drop in PSA Screening, Increase in Metastatic Prostate Cancers medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.